Tolmar

FENSOLVI

Manufacturer:

Tolmar

Fensolvi HCPCS:

J1951

HCPCS Code Descriptor:

Injection, leuprolide acetate for depot suspension (fensolvi), 0.25 mg

Category:

J Code

Fensolvi NDCs:

62935-0153-50, 62935-0163-60

Primary Type:

Growth Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Syringe

Route of Administration:

Subcutaneous

Fensolvi CPT Codes:

Potential CPT administration codes for Fensolvi can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Fensolvi:

FENSOLVI is a Growth Disorder drug manufactured by Tolmar and administered via the Subcutaneous route of administration. The J Code: J1951 is aligned to the drug FENSOLVI.

FENSOLVI is a gonadotropin releasing hormone (GnRH) agonist commonly used to treat central precocious puberty (CPP). It works by initially stimulating GnRH receptors and subsequently downregulating them. It is also a strong inhibitor of lutenizing hormone and follicular stimulating hormone, both of which are produced at the onset of puberty. FENSOLVI (J1951) is typically prescribed in pediatric patients age 2 and older.

ACCESS PRICING AND MORE BY REGISTERING

J1951 Added Date:

July 1, 2021

J1951 Effective Date:

July 1, 2021

J1951 Termination Date:

HCPCS Active

Fensolvi billing and coding information can be found through Tolmar at the link below:
Fensolvi patient assistance information can be found through Fensolvi TotalSolutions at the URL: https://info.fensolvi.com/all-topics/support/fensolvi-totalsolutions/
FENSOLVI prescribing information can be found at the link below:
Information regarding FENSOLVI’s side effects can be found at MedlinePlus